Achieve Life Sciences, Inc. Contractual Obligation, to be Paid, Year Four and Five
Achieve Life Sciences, Inc. (ACHV) had Contractual Obligation, to be Paid, Year Four and Five of $5.00 thousand as of 2020-09-30, per its 10-Q filed 2020-11-12.
Discontinued › Notes › Commitment and Contingencies › Contractual Obligation, Fiscal Year Maturity
us-gaap:ContractualObligationDueInFourthAndFifthYear · last filed 2020-11-12
- 2020-09-30: Contractual Obligation, to be Paid, Year Four and Five $5.00K.
- 2020-06-30: Contractual Obligation, to be Paid, Year Four and Five $5.00K.
- 2020-03-31: Contractual Obligation, to be Paid, Year Four and Five $5.00K.
- 2019-12-31: Contractual Obligation, to be Paid, Year Four and Five $6.00K.
| Period end | Contractual Obligation, to be Paid, Year Four and Five |
|---|---|
| 2020-09-30 | $5.00K 10-Q · filed 2020-11-12 |
| 2020-06-30 | $5.00K 10-Q · filed 2020-08-06 |
| 2020-03-31 | $5.00K 10-Q · filed 2020-05-14 |
| 2019-12-31 | $6.00K 10-K · filed 2020-03-13 |
| 2019-09-30 | $70.00K 10-Q · filed 2019-11-06 |
| 2019-06-30 | $72.00K 10-Q · filed 2019-08-08 |
| 2019-03-31 | $70.00K 10-Q · filed 2019-05-15 |
| 2018-12-31 | $69.00K 10-K · filed 2019-03-14 |
| 2017-12-31 | $25.00K 10-K · filed 2018-03-01 |
| 2017-06-30 | $9.00K 10-Q · filed 2017-07-31 |
| 2017-03-31 | $9.00K 10-Q · filed 2017-05-15 |
| 2016-12-31 | $9.00K 10-K · filed 2017-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |